Pharma-Bio Serv, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pharma-Bio Serv, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Pharma-Bio Serv, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$382K, a 183% decline year-over-year.
  • Pharma-Bio Serv, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$1.19M, a 189% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2023 was $1.12M, a 4.9% decline from 2022.
  • Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2022 was $1.17M.
  • Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2021 was -$3.85M, a 273% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1.19M -$382K -$842K -183% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 -$343K -$313K -$693K -182% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $350K -$438K -$767K -233% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $1.12M -$51.8K -$221K -131% Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 $1.34M $460K +$91K +24.6% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 $1.25M $380K +$99.4K +35.4% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $1.15M $329K -$27.2K -7.65% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $1.17M $169K +$4.97M Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 -$3.79M $370K +$9.02K +2.5% May 1, 2022 Jul 31, 2022 10-Q 2023-09-14
Q1 2022 -$3.8M $281K +$15.9K +5.99% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 -$3.82M $356K +$36.7K +11.5% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 -$3.85M -$4.8M -$4.95M -3263% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 $1.1M $360K -$456K -55.9% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 $1.55M $265K -$456K -63.2% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $2.01M $319K -$218K -40.5% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $2.23M $152K -$236K -60.9% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 $2.46M $817K +$456K +126% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $2.01M $720K +$243K +51% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 $1.76M $537K +$65.7K +14% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-17
Q3 2019 $1.7M $388K -$109K -22% Aug 1, 2019 Oct 31, 2019 10-K 2021-02-01
Q2 2019 $1.81M $361K -$361K -50% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $2.17M $477K +$486K Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q4 2018 $1.68M $471K +$2.94M Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 -$1.26M $497K +$372K +298% Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 -$1.63M $722K +$916K May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 -$2.55M -$8.68K +$316K +97.3% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 -$2.87M -$2.47M -$2.09M -544% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 -$778K $125K +$575K Aug 1, 2017 Oct 31, 2017 10-K 2019-01-29
Q2 2017 -$1.35M -$194K -$73.5K -60.8% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 -$1.28M -$325K -$419K -443% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
Q4 2016 -$860K -$384K -$768K -200% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 -$91.8K -$450K -$1.02M -180% Aug 1, 2016 Oct 31, 2016 10-K 2018-01-29
Q2 2016 $924K -$121K -$616K -124% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 $1.54M $94.6K -$297K -75.9% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-14
Q4 2015 $1.84M $384K +$55.7K +17% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 $1.78M $566K -$353K -38.5% Aug 1, 2015 Oct 31, 2015 10-K 2017-01-31
Q2 2015 $2.13M $495K -$203K -29.1% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 $2.34M $392K -$27.3K -6.51% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-14
Q4 2014 $2.36M $328K -$499K -60.3% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 $2.86M $919K -$581K -38.7% Aug 1, 2014 Oct 31, 2014 10-K 2016-01-29
Q2 2014 $3.45M $698K -$835K -54.5% May 1, 2014 Jul 31, 2014 10-Q 2015-09-14
Q1 2014 $4.28M $419K -$1.33M -76% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 $5.61M $828K -$463K -35.9% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 $6.07M $1.5M +$127K +9.25% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-29
Q2 2013 $5.94M $1.53M -$39.2K -2.5% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 $5.98M $1.75M +$322K +22.6% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-16
Q4 2012 $5.66M $1.29M -$71.6K -5.26% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $5.73M $1.37M +$343K +33.3% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 $5.39M $1.57M +$405K +34.7% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 $4.99M $1.43M +$689K +93.5% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 $4.3M $1.36M +$844K +163% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-18
Q3 2011 $3.45M $1.03M Aug 1, 2011 Oct 31, 2011 10-K 2013-01-29
Q2 2011 $1.17M +$963K +470% May 1, 2011 Jul 31, 2011 10-Q 2012-09-14
Q1 2011 $737K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 $518K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-16
Q2 2010 $205K May 1, 2010 Jul 31, 2010 10-Q 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.